arrow
R

Ronjon Chakraverty

University of Oxford
H指数:45
被引数:9,277

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Advancing the Integration of ‘Basic/Fundamental’ and Translational Cellular and Gene Therapy Science within the EBMT: Accelerating the Pathway to Progress

推进EBMT内“基础/根本”与转化细胞及基因治疗科学的整合:加速通往进步的路径

2025-08-070
PRE
Measure selection for an electronic patient-reported outcome (ePRO) system for CAR T-cell therapy patients: a modified Delphi consensus study

电子患者报告结局(ePRO)系统在CAR T细胞治疗患者中的应用:一项改良德尔菲共识研究

2025-06-010
OA
The Role of the Bone Marrow Immune Niche in Preventing Relapse in Adult B-ALL Following Reduced Intensity Conditioning Allogeneic HSCT

骨髓免疫微环境在降低强度预处理的异基因造血干细胞移植后成人B-ALL中预防复发的的作用

BLOOD
IF23.1
2024-11-050
PRE
Redirection to the bone marrow improves T cell persistence and antitumor functions
2018-04-0938
OAAI
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells (vol 24, pg 282, 2018)
2018-04-0113
OAAI
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

索拉非尼通过在FLT3-ITD-mutant白血病细胞中产生IL-15促进小鼠和人类的移植物抗白血病活性

2018-02-12236
OAAI
Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation

间充质基质细胞的凋亡诱导体内受体介导的免疫调节

2017-11-15502
OAAI